Uncemented total hip arthroplasty can be used safely in the elderly population
| Autor: | Faiz J Khan, James P. Waddell, Michael H Lewis, Peter M Lewis, Jacob R Feathers, Keith H Morris |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Orthopedic surgery
030222 orthopedics medicine.medical_specialty Hip business.industry General Engineering Tariff Reverse Hybrid Arthroplasty Cemented 03 medical and health sciences 0302 clinical medicine Elderly Uncemented Elderly population Patient-reported outcome measures Physical therapy medicine Total hip arthroplasty 030212 general & internal medicine business RD701-811 |
| Zdroj: | Bone & Joint Open Bone & Joint Open, Vol 2, Iss 5, Pp 293-300 (2021) |
| ISSN: | 2633-1462 |
| Popis: | Aims “Get It Right First Time” (GIRFT) and NHS England’s Best Practice Tariff (BPT) have published directives advising that patients over the ages of 65 (GIRFT) and 69 years (BPT) receiving total hip arthroplasty (THA) should receive cemented implants and have brought in financial penalties if this policy is not observed. Despite this, worldwide, uncemented component use has increased, a situation described as a ‘paradox’. GIRFT and BPT do, however, acknowledge more data are required to support this edict with current policies based on the National Joint Registry survivorship and implant costs. Methods This study compares THA outcomes for over 1,000 uncemented Corail/Pinnacle constructs used in all age groups/patient frailty, under one surgeon, with identical pre- and postoperative pathways over a nine-year period with mean follow-up of five years and two months (range: nine months to nine years and nine months). Implant information, survivorship, and regular postoperative Oxford Hip Scores (OHS) were collected and two comparisons undertaken: a comparison of those aged over 65 years with those 65 and under and a second comparison of those aged 70 years and over with those aged under 70. Results Overall revision rate was 1.3% (13/1,004). A greater number of revisions were undertaken in those aged over 65 years, but numbers were small and did not reach significance. The majority of revisions were implant-independent. Single component analysis revealed a 99.9% and 99.6% survival for the uncemented cup and femoral component, respectively. Mean patient-reported outcome measures (PROMs) improvement for all ages outperformed the national PROMs and a significantly greater proportion of those aged over 65/69 years reached and maintained a meaningful improvement in their OHS earlier than their younger counterparts (p < 0.05/0.01 respectively). Conclusion This study confirms that this uncemented THA system can be used safely and effectively in patient groups aged over 65 years and those over 69 years, with low complication and revision rates. Cite this article: Bone Jt Open 2021;2(5):293–300. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|